The epidemiology of drug-resistant tuberculosis in Bulawayo and Matabeleland South provinces, Zimbabwe 2017.

ABSTRACT:

Objective

To investigate determinants of drug resistance and treatment outcomes among patients with drug-resistant tuberculosis (DR-TB).

Design

This was a cross-sectional study on patients diagnosed with DR-TB in Bulawayo and Matabeleland South provinces, 2015.

Results

A total of 129 participants were identified. DR-TB patients were 3.4 times more likely to have been treated previously for sensitive TB (95% confidence interval 1.3-9.2). Approximately 88.5% of DR-TB patients were diagnosed before completing the sensitive TB course and another 82.1% developed DR-TB within 6 months of completing sensitive TB treatment. The likelihood diminished with increasing time interval, becoming less likely at >12 months post-treatment. Most DR-TB patients (87.5%) were likely to hav

SUBMITTER: Mugauri Dumisani H 

PROVIDER: S-EPMC9216256 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature